MONTECET
Montelukast Sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor.
Levocetirizine HCL, is an orally active H1-receptor antagonist.
SALBUGEN
Each 5 mL of Salbugen Syrup contains 2 mg of Salbutamol Sulfate that appears as clear cherry red colored syrup. It comes in strawberry flavor with a characteristics sweet fruit taste.
Label
Formulation and Dosage
Indication
Distribution
Label
2 mg per 5 mL
Syrup
SELECTIVE BETA-2-ADRENORECEPTOR AGONIST
Formulation and Dosage
FORMULATION:
Each 5 mL (1 teaspoonful) contains:
Salbutamol (as sulfate)………………………………………….2 mg
DOSAGE:
Adults: 1 – 2 teaspoonfuls (5 mL – 10 mL)
Children: 6 -12 years: 1 teaspoonful (5 mL)
2 – 5 years: ½ teaspoonful (2.5 mL)
To be taken every 8 hours or as prescribed by the physician.
INDICATION:
Indication
For the treatment and prevention of bronchospasm in bronchial asthma, chronic bronchitis, emphysema, acute dyspnoea and other diseases of the lungs which may be complicated by bronchospasm.
Store at temperatures not exceeding 30c. Protect from light.
Distribution
FDA Registration Number: DRP-6795-01
Manufacturer: Lloyd Laboratories, Inc.
Product Categories
Share this Product:
Other Products
Q-CETYL
Acetylcysteine exerts an intensive mucolytic-fluidifying action on the mucous and mucopurulent secretions by depolymerizing the mucoprotein complexes and the nucleic acids which confer viscosity to the vitreous and purulent component of the sputum and other secretions.
Q-MEP
Omeprazole is used to treat excess stomach acid in conditions such as non cancerous stomach ulcers, gastroesophageal reflux disease (GERD), active duodenal ulcer, Zollinger-Ellison syndrome and erosive esophagitis. Omeprazole works by blocking gastric acid production and is from the group of medicines called proton pump inhibitors.
SALBUGEN PLUS
The combination of salbutamol with guaifenesin is designed to relieve respiratory obstruction and improve pulmonary ventilation. Respiratory disorders where bronchospasm and excessive secretion of tenacious mucus are complicating factors, e.g. bronchial asthma, chronic bronchitis and emphysema.